{"schema_version":"secwatch.filing_event.v1","accession":"0001773751-22-000162","form_type":"8-K","ticker":"HIMS","cik":"0001773751","company_name":"Hims & Hers Health, Inc.","filed_at":"2022-08-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:56.988296+00:00","generated_at":"2026-06-24T02:57:37.522761+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Hims & Hers Q2 revenue $113.6M (+87% YoY); raises FY22 revenue guidance to $470-485M","bullets":["Revenue of $113.6M, up 87% YoY; net loss $(19.7M) vs $(9.2M) prior year.","Quarterly net new subscriptions >100k, total subscriptions 817k, up 80% YoY.","Raises FY22 revenue guidance to $470-485M and Adjusted EBITDA guidance to $(27)M-$(20)M.","Gross margin 77% (78% prior year); expects Adjusted EBITDA profitability within next four quarters.","Launched Hers mobile app and 6 new Wellness Essentials supplements for women."],"urls":{"canonical":"https://secwatch.observer/filing/0001773751-22-000162","json":"https://secwatch.observer/filing/0001773751-22-000162.json","markdown":"https://secwatch.observer/filing/0001773751-22-000162.md","text":"https://secwatch.observer/filing/0001773751-22-000162.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1773751/000177375122000162/0001773751-22-000162-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1773751/000177375122000162/hims-20220808.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T02:57:37.522761+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}